Thursday, 11 April 2013

Power of the Market

#MSBlog #MSResearch Do the French have a case?

Spencer and Whalen. Change France? Sanofi Finds It Can't. Wall Street Journal April 10, 2013, 7:25 p.m. ET

..... TOULOUSE, France—Last July, French drug maker Sanofi told research scientists here that their lab didn't have a future. The company said the facility in southwestern France was too expensive and wasn't making enough discoveries to remain part of its global research organization....

...... Employees staged weekly protests called "Thursdays of Anger" and challenged Sanofi's decision in court. They also found a strong ally: the French government. Industry Minister Arnaud Montebourg told parliament he wouldn't tolerate profitable companies slashing jobs .....

.... The pressure is high in France, where it costs Sanofi significantly more money and 20% more time to develop a new drug compared with competitors, according to a report unions say Sanofi sent them. .....

....The country is still home to half of Sanofi's R&D staff, but the French labs have failed to produce any significant new medicine in 20 years, Chief Executive Chris Viehbacher said last fall. Asked about the negative reaction to Sanofi's reorganization plans, Mr. Viehbacher said: "We're doing what we think is best for the company." .....

Click here to read full article 

"This issue may be of of interest to MSers as Genzyme-Sanofi have developed two drugs for MSers; teriflunomide and alemtuzumab. We need to wait and see how this plays out and whether or not it impacts on what the company charges for these products and what kind of deal the French government will be able to negotiate."

3 comments:

  1. Clearly Sanofi R & D did not develop discovery alemtuzumab, they bought it in, just like for example Novartis bought in Fingolimod which was invented in Japan I believe. Big pharma have been binning their own R & D departments.

    It is interesting how the French are much more millitant in this aspect, Loads of British Science jobs have been canned e.g.GSK neuroscience moved to China from Stevenage. Where was the UK Government.

    ReplyDelete
  2. Clearly Sanofi R & D did not develop discovery alemtuzumab, they bought it in, just like for example Novartis bought in Fingolimod which was invented in Japan I believe. Big pharma have been binning their own R & D departments.

    It is interesting how the French are much more millitant in this aspect, Loads of British Science jobs have been canned e.g.GSK neuroscience moved to China from Stevenage. Where was the UK Government.

    ReplyDelete
    Replies
    1. Exactly. You can say what you like about the French but they are much more proactive in protesting these decisions. I'm sure in the not too distant future companies like GSK will come to greatly regret moving their research infrastructure offshore to places like China etc, where, day I say it standards of scientific rectitude may not be as high as they are here.

      Delete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.